Insider NameBuy/SellCompany NameTickerAmountShares Change
Jan 17, 2025Jan 18, 2025Rawcliffe Adrian
CEO
SellAdaptimmune Therapeutics PlcADAP$0.58$17,773-40.84%
Jan 13, 2025Jan 15, 2025Rawcliffe Adrian
CEO
SellAdaptimmune Therapeutics PlcADAP$0.58$34,639-58.89%
Jan 16, 2024Jan 17, 2024Rawcliffe Adrian
CEO
SellAdaptimmune Therapeutics PlcADAP$0.7$27,594-46.76%
Jan 11, 2024Jan 12, 2024Rawcliffe Adrian
CEO
SellAdaptimmune Therapeutics PlcADAP$0.85$24,734-52.53%
Sep 01, 2023Sep 01, 2023Rawcliffe Adrian
CEO
SellAdaptimmune Therapeutics PlcADAP$0.78$1,874-41.06%
Jun 27, 2023Jun 28, 2023Rawcliffe Adrian
CEO
SellAdaptimmune Therapeutics PlcADAP$0.92$2,146-39.87%
Jan 17, 2023Jan 18, 2023Rawcliffe Adrian
CEO
SellAdaptimmune Therapeutics PlcADAP$1.86$18,686-42.96%
Jan 11, 2023Jan 13, 2023Rawcliffe Adrian
CEO
SellAdaptimmune Therapeutics PlcADAP$1.72$54,791-56.11%
Jan 04, 2023Jan 05, 2023Rawcliffe Adrian
CEO
SellAdaptimmune Therapeutics PlcADAP$1.69$8,594-43.34%
Sep 01, 2022Sep 02, 2022Rawcliffe Adrian
CEO
SellAdaptimmune Therapeutics PlcADAP$1.97$4,993-43.34%
Jun 27, 2022Jun 28, 2022Rawcliffe Adrian
CEO
SellAdaptimmune Therapeutics PlcADAP$1.63$4,176-43.78%
Jan 18, 2022Jan 19, 2022Rawcliffe Adrian
CEO
SellAdaptimmune Therapeutics PlcADAP$3.19$35,416-47.40%
Jan 11, 2022Jan 14, 2022Rawcliffe Adrian
CEO
SellAdaptimmune Therapeutics PlcADAP$3.55$61,877-83.84%
Jan 04, 2022Jan 06, 2022Rawcliffe Adrian
CEO
SellAdaptimmune Therapeutics PlcADAP$4.06$22,483-47.27%
Sep 01, 2021Sep 02, 2021Rawcliffe Adrian
CEO
SellAdaptimmune Therapeutics PlcADAP$5.2$14,452-47.54%
Jun 28, 2021Jun 29, 2021Rawcliffe Adrian
CEO
SellAdaptimmune Therapeutics PlcADAP$4.37$12,210-47.74%
Jan 19, 2021Jan 20, 2021Rawcliffe Adrian
CEO
SellAdaptimmune Therapeutics PlcADAP$5.67$56,009-42.20%
Jan 12, 2021Jan 13, 2021Rawcliffe Adrian
CEO
SellAdaptimmune Therapeutics PlcADAP$6.15$16,654-42.28%
Jan 04, 2021Jan 06, 2021Rawcliffe Adrian
CEO
SellAdaptimmune Therapeutics PlcADAP$5.33$26,464-42.44%
Sep 01, 2020Sep 03, 2020Rawcliffe Adrian
CEO
SellAdaptimmune Therapeutics PlcADAP$8.51$23,637-47.44%
Aug 03, 2020Aug 05, 2020Rawcliffe Adrian
CEO
SellAdaptimmune Therapeutics PlcADAP$9.25$25,789-47.64%
Jan 14, 2020Jan 16, 2020Rawcliffe Adrian
CEO
SellAdaptimmune Therapeutics PlcADAP$5.13$16,616-50.55%
Jan 06, 2020Jan 08, 2020Rawcliffe Adrian
CEO
SellAdaptimmune Therapeutics PlcADAP$1.2$7,080-50.41%
Jan 14, 2019Jan 17, 2019Rawcliffe Adrian
CFO
SellAdaptimmune Therapeutics PlcADAP$5.37$16,559-48.17%
Mar 20, 2018Mar 23, 2018Rawcliffe Adrian
CFO
SellAdaptimmune Therapeutics PlcADAP$1.71$1M-0
Sign in to view more
To unlock more features with more data and insights.
Forgot your password?
By continuing, you agree to our Terms of Service and Privacy Policy.